Nye farmakologiske behandlingsmodaliteter ved type 2-diabetes

Medicin og biovidenskab

• Glucagon Receptors 100%
• Type 2 Diabetes Mellitus 96%
• Sodium-Glucose Transporter 2 Inhibitors 92%
• Symporters 87%
• Glucokinase 86%
• Pharmacology 85%
• Dipeptidyl-Peptidase IV Inhibitors 84%
• Incretins 83%
• Glucagon-Like Peptide-1 Receptor 82%
• Glucose 80%
• Renal Elimination 75%
• G-Protein-Coupled Receptors 64%
• Hypoglycemic Agents 61%
• Weight Loss 52%
• Hormones 45%
• Insulin 43%
• Peptides 40%